The U.S. Department of the Treasury and IRS recently issued temporary regulations that provide an immediately effective framework for establishing and administering “Trump Accounts,” including broad automatic enrollment and large-scale contributions funded by governmental and charitable donors. The regulations became
Health Care and Life Sciences
Illinois Assisted Living Update: New Assessment, Dementia Care and Enforcement Requirements
The Illinois General Assembly recently enacted HB 3392, which amends several provisions of the Illinois Assisted Living and Shared Housing Act (“Act”). The legislation imposes new assessment requirements, modifies qualifications for assisted living directors, updates medication administration provisions, revises…
DOJ Memo Sharpens Its Corporate Fraud Focus: Insights from the National Fraud Enforcement Division on Its Corporate Enforcement Priorities
On October 1, 2026, Colin M. McDonald, Assistant Attorney General for the National Fraud Enforcement Division (“NFED” or the “Fraud Division”), issued a memorandum (the “Memo”) announcing key priorities of the Fraud Division’s Corporate Enforcement Section. The Memo follows significant…
2025 to First-Half 2026 Marks a Breakout Time for CVRs
Sally Wagner Partin and Sharon Flanagan look at the results of Sidley’s latest survey of contingent value rights (“CVRs”), analyzing recent trends in life sciences public M&A and finding a record share of deals using a CVR, particularly in biopharma…
Beyond Animal Testing: FDA’s 2026 Framework for Fit-for-Purpose NAMs
In September 2026, FDA took another significant step toward integrating new approach methodologies, or NAMs, into drug development by issuing a Direct Final Rule on Nonclinical Testing Terminology (the “September 2026 direct final rule”).[1] Read together with FDA’s March
…
Court Grants Summary Judgment in Kickback-Based FCA Case, Holding Relator Failed to Prove Remuneration or Willfulness
The District of Massachusetts recently granted summary judgment to Janssen Biotech, Inc. (“Janssen”) in a declined False Claims Act qui tam. The relator alleged that Janssen gave physician practices free services to induce them to prescribe its infusible drugs, Remicade…
Heartland Conference Previews DOJ, State AG, and Regulatory Enforcement Priorities for 2026–27
On September 30, 2026, the University of Missouri-Kansas City School of Law hosted the inaugural Heartland Government Enforcement & Investigations Conference. The day-long program brought together federal prosecutors, judges, state regulators, in-house counsel, and private practitioners across seven substantive sessions…
Congress Proposes Bill Taking Aim at Corporate Control and Investment in Medical Practices
On September 16, 2026, Senators Ron Wyden, Jeff Merkley, and Elizabeth Warren, together with Representatives Val Hoyle, Alexandria Ocasio-Cortez, and Suhas Subramanyam, introduced the Stop Corporate Takeovers of Physicians Act of 2026 (the “Act”) in the House and…
Escaping Flatland: Biological World Models and the Laplace Engine
How to Fight Back Against the Gap Between Medical Need and Insurance Coverage
When a physician prescribes a necessary treatment but your insurance company denies coverage, the resulting frustration can feel overwhelming. Many patients face situations where their medical needs diverge sharply from what their insurance plan will actually pay for. This gap…
